News

Better bowel cancer screens in Scotland

01-Mar-07

The Scottish approach to bowel cancer screening will be more efficient and better received by patients than that being rolled out in England and Wales, experts say.
Under the Scottish programme, which will be rolled out to all aged 50-74 from June, patients with a weakly positive guaiac faecal occult blood test (FOBT) will undergo the more sensitive faecal immunochemical test (FIT) before colonoscopy.

In England, which began roll-out of its screening programme in April 2006, a weakly positive FOBT is followed by a repeat FOBT. Colonoscopy then follows.

Wales plans to begin roll-out of a similar scheme in April. Northern Ireland is working towards introducing a screening programme in 2009.

Last year, researchers from the Scottish Bowel Cancer Screening Laboratory in Dundee showed that using FIT in this way could reduce the need for colonoscopy by 30 per cent (GP, 13 January 2006).

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Registrar

How to apply for your certificate

Applying to the RCGP for your CCT recommendation now takes three clicks, writes Fiona Erasmus. Read more

A question of capacity

Medicolegal advisor, Dr John Holden addresses some dilemmas on consent that may be faced by GPs. Read more

Workplace-based assessment

The WPBA should be seen as a developmental process, says the RCGP's Dr Jane Mamelok. Read more

Show all articles

 

Latest Clinical Articles

Endometriosis

Contributed by Mr Michael Booker, consultant obstetrician & gynaecologist, and fertility specialist ... Read more

Primary hyperparathyroidism

Contributed by Mr David Scott-Coombes, consultant endocrine surgeon at the University Hospital of Wa... Read more

Clinical Review - Headache in children

Contributed by Dr David Kernick, a GPSI in headache, based in Exeter. Read more

Show all clinical articles

MIMS Product News

Toviaz

New drug - Toviaz

Pfizer has launched Toviaz (fesoterodine), a once-daily treatment for the symptoms of overactive bla... Read more

New drug - Tasigna

Novartis has launched Tasigna (nilotinib), a new antineoplastic agent for Philadelphia chromosome po... Read more

Ciproxin licensed for UTI in children

The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line tr... Read more

Jobs

 

Job of the Week